Whole Blood Expression Pattern of Inflammation and Redox Genes in Mild Alzheimer’s Disease

References

• Kolanko MA, Win Z, Loreto F, et al. Amyloid PET imaging in clinical practice. Pract Neurol. 2020;20(6):451–462. doi:10.1136/practneurol-2019-002468
   PubMedGoogle Scholar
• McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263–269. doi:10.1016/j.jalz.2011.03.005
   PubMed Web of Science ®Google Scholar
• Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614–629. doi:10.1016/S1474-4422(14)70090-0
   PubMed Web of Science ®Google Scholar
• Toledo JB, Xie SX, Trojanowski JQ, Shaw LM. Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI. Acta Neuropathol. 2013;126(5):659–670. doi:10.1007/s00401-013-1151-4
   PubMed Web of Science ®Google Scholar
• Sutphen CL, McCue L, Herries EM, et al. Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer’s disease. Alzheimers Dement. 2018;14(7):869–879. doi:10.1016/j.jalz.2018.01.012
   PubMed Web of Science ®Google Scholar
• Park SA, Han SM, Kim CE. New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease. Exp Mol Med. 2020;52(4):556–568. doi:10.1038/s12276-020-0418-9
   PubMed Web of Science ®Google Scholar
• Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019;90(8):870–881. doi:10.1136/jnnp-2018-320106
   PubMed Web of Science ®Google Scholar
• Guarner V, Rubio-Ruiz ME. Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease. Interdiscip Top Gerontol. 2015;40:99–106. doi:10.1159/000364934
   PubMedGoogle Scholar
• Guzman-Martinez L, Maccioni RB, Andrade V, Navarrete LP, Pastor MG, Ramos-Escobar N. Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol. 2019;10:1008. doi:10.3389/fphar.2019.01008
   PubMed Web of Science ®Google Scholar
• Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer’s disease. Alzheimers Dement. 2018;4:575–590. doi:10.1016/j.trci.2018.06.014
   Google Scholar
• Onyango IG, Jauregui GV, Čarná M, Bennett JP, Stokin GB. Neuroinflammation in Alzheimer’s disease. Biomedicines. 2021;9(5):524. doi:10.3390/biomedicines9050524
   PubMed Web of Science ®Google Scholar
• Milind N, Preuss C, Haber A, et al. Transcriptomic stratification of late-onset Alzheimer’s cases reveals novel genetic modifiers of disease pathology. PLOS Genet. 2020;16(6):e1008775. doi:10.1371/journal.pgen.1008775
   PubMed Web of Science ®Google Scholar
• Passamonti L, Tsvetanov KA, Jones PS, et al. Neuroinflammation and functional connectivity in Alzheimer’s disease: interactive influences on cognitive performance. J Neurosci. 2019;39(36):7218–7226. doi:10.1523/JNEUROSCI.2574-18.2019
   PubMed Web of Science ®Google Scholar
• Fu W-Y, Wang X, Ip NY. Targeting neuroinflammation as a therapeutic strategy for Alzheimer’s disease: mechanisms, drug candidates, and new opportunities. ACS Chem Neurosci. 2019;10(2):872–879. doi:10.1021/acschemneuro.8b00402
   PubMed Web of Science ®Google Scholar
• Chen X, Hu Y, Cao Z, Liu Q, Cheng Y. Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer’s Disease, Parkinson’s disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Front Immunol. 2018;9:2122. doi:10.3389/fimmu.2018.02122
   PubMed Web of Science ®Google Scholar
• Suárez-Calvet M, Capell A, Araque Caballero MÁ, et al. CSF progranulin increases in the course of Alzheimer’s disease and is associated with sTREM2, neurodegeneration and cognitive decline. EMBO Mol Med. 2018;10(12). doi:10.15252/emmm.201809712
   PubMed Web of Science ®Google Scholar
• Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer’s disease. Nucleic Acids Res. 2007;35(22):7497–7504. doi:10.1093/nar/gkm821
   PubMed Web of Science ®Google Scholar
• Feng Y, Wang X. Antioxidant therapies for Alzheimer’s disease. Oxid Med Cell Longev. 2012;2012:472932. doi:10.1155/2012/472932
   PubMed Web of Science ®Google Scholar
• Mecocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease. Ann Neurol. 1994;36(5):747–751. doi:10.1002/ana.410360510
   PubMed Web of Science ®Google Scholar
• Sakakibara R, Kawai T. Cerebrospinal fluid oxidative stress markers in Alzheimer’s disease. Neurol Clin Neurosci. 2020;8(5):232–240. doi:10.1111/ncn3.12413
   Web of Science ®Google Scholar
• Bubici C, Papa S, Dean K, Franzoso G. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene. 2006;25(51):6731–6748. doi:10.1038/sj.onc.1209936
   PubMed Web of Science ®Google Scholar
• Verdile G, Keane KN, Cruzat VF, et al. Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer’s disease. Mediators Inflamm. 2015;2015:105828. doi:10.1155/2015/105828
   PubMed Web of Science ®Google Scholar
• Mattke S, Cho SK, Bittner T, Hlávka J, Hanson M. Blood-based biomarkers for Alzheimer’s pathology and the diagnostic process for a disease-modifying treatment: projecting the impact on the cost and wait times. Alzheimers Dement. 2020;12(1):e12081. doi:10.1002/dad2.12081
   Web of Science ®Google Scholar
• Leuzy A, Cullen NC, Mattsson-Carlgren N, Hansson O. Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer’s disease. Curr Opin Neurol. 2021;34(2):266–274. doi:10.1097/WCO.0000000000000904
   PubMed Web of Science ®Google Scholar
• Franceschi C, Campisi J. Chronic inflammation (Inflammaging) and its potential contribution to age-associated diseases. Journals Gerontol Ser A Biol Sci Med Sci. 2014;69(Suppl 1):S4–S9. doi:10.1093/gerona/glu057
   PubMed Web of Science ®Google Scholar
• Jha NK, Jha SK, Kar R, Nand P, Swati K, Goswami VK. Nuclear factor-kappa β as a therapeutic target for Alzheimer’s disease. J Neurochem. 2019;150(2):113–137. doi:10.1111/jnc.14687
   PubMed Web of Science ®Google Scholar
• Leandro GS, Evangelista AF, Lobo RR, Xavier DJ, Moriguti JC, Sakamoto-Hojo ET. Changes in expression profiles revealed by transcriptomic analysis in peripheral blood mononuclear cells of Alzheimer’s disease patients. J Alzheimers Dis. 2018;66(4):1483–1495. doi:10.3233/JAD-170205
   PubMed Web of Science ®Google Scholar
• Paouri E, Georgopoulos S. Systemic and CNS Inflammation crosstalk: implications for Alzheimer’s disease. Curr Alzheimer Res. 2019;16(6):559–574. doi:10.2174/1567205016666190321154618
   PubMed Web of Science ®Google Scholar
• Lee T, Lee H. Prediction of Alzheimer’s disease using blood gene expression data. Sci Rep. 2020;10(1):3485. doi:10.1038/s41598-020-60595-1
   PubMedGoogle Scholar
• Phongpreecha T, Fernandez R, Mrdjen D, et al. Single-cell peripheral immunoprofiling of Alzheimer’s and Parkinson’s diseases. Sci Adv. 2020;6(48). doi:10.1126/sciadv.abd5575
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR, “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198. doi:10.1016/0022-3956(75)90026-6
   PubMed Web of Science ®Google Scholar
• Milanesi E, Manda G, Dobre M, et al. Distinctive under-expression profile of inflammatory and redox genes in the blood of elderly patients with cardiovascular disease. J Inflamm Res. 2021;14:429–442. doi:10.2147/JIR.S280328
   PubMed Web of Science ®Google Scholar
• Metsalu T, Vilo J. ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap. Nucleic Acids Res. 2015;43(W1):W566–70. doi:10.1093/nar/gkv468
   PubMed Web of Science ®Google Scholar
• Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–1160. doi:10.3758/BRM.41.4.1149
   PubMed Web of Science ®Google Scholar
• Lovestone S, Francis P, Kloszewska I, et al. AddNeuroMed–the European collaboration for the discovery of novel biomarkers for Alzheimer’s disease. Ann N Y Acad Sci. 2009;1180(1):36–46. doi:10.1111/j.1749-6632.2009.05064.x
   PubMedGoogle Scholar
• Lunnon K, Ibrahim Z, Proitsi P, et al. Mitochondrial dysfunction and immune activation are detectable in early Alzheimer’s disease blood. J Alzheimers Dis. 2012;30(3):685–710. doi:10.3233/JAD-2012-111592
   PubMed Web of Science ®Google Scholar
• Dennis G, Sherman BT, Hosack DA, et al. DAVID: database for annotation, visualization, and Integrated discovery. Genome Biol. 2003;4(5):P3.
   PubMed Web of Science ®Google Scholar
• Benjamini Y. Discovering the false discovery rate. J R Stat Soc Ser B. 2010;72(4):405–416. doi:10.1111/j.1467-9868.2010.00746.x
   Google Scholar
• Kwon AT, Arenillas DJ, Worsley Hunt R, Wasserman WW. POSSUM-3: advanced analysis of regulatory motif over-representation across genes or ChIP-Seq datasets. G3 (Bethesda). 2012;2(9):987–1002. doi:10.1534/g3.112.003202
   PubMedGoogle Scholar
• Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26(6):841–842. doi:10.1093/bioinformatics/btq033
   PubMed Web of Science ®Google Scholar
• Oki S, Ohta T, Shioi G, et al. ChIP-Atlas: a data-mining suite powered by full integration of public ChIP-seq data. EMBO Rep. 2018;19(12). doi:10.15252/embr.201846255
   PubMed Web of Science ®Google Scholar
• Dale RK, Pedersen BS, Quinlan AR. Pybedtools: a flexible Python library for manipulating genomic datasets and annotations. Bioinformatics. 2011;27(24):3423–3424. doi:10.1093/bioinformatics/btr539
   PubMed Web of Science ®Google Scholar
• Fornes O, Castro-Mondragon JA, Khan A, et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2020;48(D1):D87–D92. doi:10.1093/nar/gkz1001
   PubMed Web of Science ®Google Scholar
• Pajares M, Jiménez-Moreno N, García-Yagüe ÁJ, et al. Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy. 2016;12(10):1902–1916. doi:10.1080/15548627.2016.1208889
   PubMed Web of Science ®Google Scholar
• Naughton BJ, Duncan FJ, Murrey DA, et al. Blood genome-wide transcriptional profiles reflect broad molecular impairments and strong blood-brain links in Alzheimer’s disease. J Alzheimers Dis. 2015;43(1):93–108. doi:10.3233/JAD-140606
   PubMed Web of Science ®Google Scholar
• Maes OC, Xu S, Yu B, Chertkow HM, Wang E, Schipper HM. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging. 2007;28(12):1795–1809. doi:10.1016/j.neurobiolaging.2006.08.004
   PubMed Web of Science ®Google Scholar
• Skillbäck T, Farahmand BY, Rosén C, et al. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia. Brain. 2015;138(Pt9):2716–2731. doi:10.1093/brain/awv181
   PubMedGoogle Scholar
• Sunderland T, Linker G, Mirza N, et al. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA. 289(16):2094–2103. doi:10.1001/jama.289.16.2094
   PubMed Web of Science ®Google Scholar
• Fossati S, Ramos Cejudo J, Debure L, et al. Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer’s disease. Alzheimers Dement. 2019;11:483–492. doi:10.1016/j.dadm.2019.05.001
   Web of Science ®Google Scholar
• Hanon O, Vidal J-S, Lehmann S, et al. Plasma amyloid levels within the Alzheimer’s process and correlations with central biomarkers. Alzheimers Dement. 2018;14(7):858–868. doi:10.1016/j.jalz.2018.01.004
   PubMed Web of Science ®Google Scholar
• McKay EC, Beck JS, Khoo SK, et al. Peri-infarct upregulation of the oxytocin receptor in vascular dementia. J Neuropathol Exp Neurol. 2019;78(5):436–452. doi:10.1093/jnen/nlz023
   PubMed Web of Science ®Google Scholar
• Huang TT, Miyamoto S. Postrepression activation of NF-kappaB requires the amino-terminal nuclear export signal specific to IkappaBalpha. Mol Cell Biol. 2001;21(14):4737–4747. doi:10.1128/MCB.21.14.4737-4747.2001
   PubMed Web of Science ®Google Scholar
• Cheng Q, Cant CA, Moll T, et al. NK-kappa B subunit-specific regulation of the I kappa B alpha promoter. J Biol Chem. 1994;269(18):13551–13557.
   PubMed Web of Science ®Google Scholar
• Saha S, Buttari B, Panieri E, Profumo E, Saso L. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules. 2020;25(22):5474. doi:10.3390/molecules25225474
   PubMed Web of Science ®Google Scholar
• Vavrik ZM, Gonchar’ MG, Dudik IV, Zelenetskiĭ RG, Kulevnik II. [Teaching surgery at a stomatologic faculty]. Klin Khir. 1988;(11):41–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3221638. Russian
   Google Scholar
• Brown K, Park S, Kanno T, Franzoso G, Siebenlist U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci U S A. 1993;90(6):2532–2536. doi:10.1073/pnas.90.6.2532
   PubMed Web of Science ®Google Scholar
• Pasparakis M, Luedde T, Schmidt-Supprian M. Dissection of the NF-kappaB signalling cascade in transgenic and knockout mice. Cell Death Differ. 2006;13(5):861–872. doi:10.1038/sj.cdd.4401870
   PubMed Web of Science ®Google Scholar
• Ferreiro DU, Komives EA. Molecular mechanisms of system control of NF-kappaB signaling by IkappaBalpha. Biochemistry. 2010;49(8):1560–1567. doi:10.1021/bi901948j
   PubMed Web of Science ®Google Scholar
• Gao Z, Chiao P, Zhang X, et al. Coactivators and corepressors of NF-kappaB in IkappaB alpha gene promoter. J Biol Chem. 2005;280(22):21091–21098. doi:10.1074/jbc.M500754200
   PubMed Web of Science ®Google Scholar
• Morceau F, Duvoix A, Delhalle S, Schnekenburger M, Dicato M, Diederich M. Regulation of glutathione S-transferase P1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cells. Biochem Pharmacol. 2004;67(7):1227–1238. doi:10.1016/j.bcp.2003.10.036
   PubMed Web of Science ®Google Scholar
• De Benedictis CA, Vilella A, Grabrucker AM. The role of trace metals in Alzheimer’s disease; 2019. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31895516. Accessed November 16, 2021.
   Google Scholar
• Rivers-Auty J, Tapia VS, White CS, et al. Zinc status alters Alzheimer’s disease progression through NLRP3-dependent inflammation. J Neurosci. 2021;41(13):3025–3038. doi:10.1523/JNEUROSCI.1980-20.2020
   PubMed Web of Science ®Google Scholar
• Ashraf A, Stosnach H, Parkes HG, et al. Pattern of altered plasma elemental phosphorus, calcium, zinc, and iron in Alzheimer’s disease. Sci Rep. 2019;9(1):3147. doi:10.1038/s41598-018-37431-8
   PubMedGoogle Scholar
• Chilov D, Camenisch G, Kvietikova I, Ziegler U, Gassmann M, Wenger RH, Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1alpha. J Cell Sci. 1999;112(Pt 8):1203–1212. doi:10.1242/jcs.112.8.1203
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Ale-Agha N, Haendeler J, Ventura N. The Aryl hydrocarbon receptor (AhR) in the aging process: another puzzling role for this highly conserved transcription factor. Front Physiol. 2019;10:1561. doi:10.3389/fphys.2019.01561
   PubMed Web of Science ®Google Scholar
• Iyalomhe O, Swierczek S, Enwerem N, et al. The role of hypoxia-inducible factor 1 in mild cognitive impairment. Cell Mol Neurobiol. 2017;37(6):969–977. doi:10.1007/s10571-016-0440-6
   PubMed Web of Science ®Google Scholar
• Ramos-García NA, Orozco-Ibarra M, Estudillo E, et al. Aryl hydrocarbon receptor in post-mortem hippocampus and in serum from young, elder, and Alzheimer’s patients. Int J Mol Sci. 2020;21(6):1983. doi:10.3390/ijms21061983
   PubMed Web of Science ®Google Scholar
• Cildir G, Low KC, Tergaonkar V. Noncanonical NF-κB signaling in health and disease. Trends Mol Med. 2016;22(5):414–429. doi:10.1016/j.molmed.2016.03.002
   PubMed Web of Science ®Google Scholar
• Meyerovich K, Fukaya M, Terra LF, Ortis F, Eizirik DL, Cardozo AK. The non-canonical NF-κB pathway is induced by cytokines in pancreatic beta cells and contributes to cell death and proinflammatory responses in vitro. Diabetologia. 2016;59(3):512–521. doi:10.1007/s00125-015-3817-z
   PubMed Web of Science ®Google Scholar
• Tergaonkar V. NFκB pathway: a good signaling paradigm and therapeutic target. Int J Biochem Cell Biol. 2006;38(10):1647–1653. doi:10.1016/j.biocel.2006.03.023
   PubMed Web of Science ®Google Scholar
• Shih VF-S, Tsui R, Caldwell A, Hoffmann A. A single NFκB system for both canonical and non-canonical signaling. Cell Res. 2011;21(1):86–102. doi:10.1038/cr.2010.161
   PubMed Web of Science ®Google Scholar
• Möser CV, Stephan H, Altenrath K, et al. TANK-binding kinase 1 (TBK1) modulates inflammatory hyperalgesia by regulating MAP kinases and NF-κB dependent genes. J Neuroinflammation. 2015;12(1):100. doi:10.1186/s12974-015-0319-3
   PubMedGoogle Scholar
• Calò V, Migliavacca M, Bazan V, et al. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol. 2003;197(2):157–168. doi:10.1002/jcp.10364
   PubMed Web of Science ®Google Scholar
• Lee WJ, Ham SA, Lee GH, et al. Activation of peroxisome proliferator‐activated receptor delta suppresses BACE 1 expression by up‐regulating SOCS 1 in a JAK 2/ STAT 1‐dependent manner. J Neurochem. 2019;151(3):370–385. doi:10.1111/jnc.14715
   PubMed Web of Science ®Google Scholar
• Di Liberto G, Pantelyushin S, Kreutzfeldt M, et al. Neurons under T cell attack coordinate phagocyte-mediated synaptic stripping. Cell. 2018;175(2):458–471.e19. doi:10.1016/j.cell.2018.07.049
   PubMed Web of Science ®Google Scholar
• Bergman M, Salman H, Beloosesky Y, Djaldetti M, Bessler H. Are peripheral blood cells from patients with Alzheimer disease more sensitive to apoptotic stimuli? Alzheimer Dis Assoc Disord. 2002;16(3):156–160. doi:10.1097/00002093-200207000-00005
   PubMed Web of Science ®Google Scholar
• Tonelli C, Chio IIC, Tuveson DA. Transcriptional regulation by Nrf2. Antioxid Redox Signal. 2018;29(17):1727–1745. doi:10.1089/ars.2017.7342
   PubMed Web of Science ®Google Scholar
• Koppula P, Zhang Y, Zhuang L, Gan B. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun. 2018;38(1):12. doi:10.1186/s40880-018-0288-x
   PubMed Web of Science ®Google Scholar
• Harvey CJ, Thimmulappa RK, Singh A, et al. Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic Biol Med. 2009;46(4):443–453. doi:10.1016/j.freeradbiomed.2008.10.040
   PubMed Web of Science ®Google Scholar
• Jaganjac M, Milkovic L, Sunjic SB, Zarkovic N. The NRF2, thioredoxin, and glutathione system in tumorigenesis and anticancer therapies. Antioxidants (Basel, Switzerland). 2020;9(11). doi:10.3390/antiox9111151
   Google Scholar
• Mandal PK, Saharan S, Tripathi M, Murari G. Brain glutathione levels – a novel biomarker for mild cognitive impairment and Alzheimer’s disease. Biol Psychiatry. 2015;78(10):702–710. doi:10.1016/j.biopsych.2015.04.005
   PubMed Web of Science ®Google Scholar
• Li W, Febbraio M, Reddy SP, Yu D-Y, Yamamoto M, Silverstein RL. CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs. J Clin Invest. 2010;120(11):3996–4006. doi:10.1172/JCI42823
   PubMed Web of Science ®Google Scholar
• Li L, Dong H, Song E, Xu X, Liu L, Song Y. Nrf2/ARE pathway activation, HO-1 and NQO1 induction by polychlorinated biphenyl quinone is associated with reactive oxygen species and PI3K/AKT signaling. Chem Biol Interact. 2014;209:56–67. doi:10.1016/j.cbi.2013.12.005
   PubMed Web of Science ®Google Scholar
• Jain A, Lamark T, Sjøttem E, et al. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem. 2010;285(29):22576–22591. doi:10.1074/jbc.M110.118976
   PubMed Web of Science ®Google Scholar
• Osama A, Zhang J, Yao J, Yao X, Fang J. Nrf2: a dark horse in Alzheimer’s disease treatment. Ageing Res Rev. 2020;64:101206. doi:10.1016/j.arr.2020.101206
   PubMed Web of Science ®Google Scholar
• Zhong Z, Sanchez-Lopez E, Karin M. Autophagy, inflammation, and immunity: a troika governing cancer and its treatment. Cell. 2016;166(2):288–298. doi:10.1016/j.cell.2016.05.051
   PubMed Web of Science ®Google Scholar
• Uddin MS, Stachowiak A, Al MA, et al. Autophagy and Alzheimer’s disease: from molecular mechanisms to therapeutic implications. Front Aging Neurosci. 2018;10:04. doi:10.3389/fnagi.2018.00004
   PubMed Web of Science ®Google Scholar
• Cui B, Lin H, Yu J, Yu J, Hu Z. Autophagy and the immune response. Adv Exp Med Biol. 2019;1206:595–634. doi:10.1007/978-981-15-0602-4_27
   PubMed Web of Science ®Google Scholar
• Meyer M, Schreck R, Müller JM, Baeuerle PA. Redox control of gene expression by eukaryotic transcription factors NF-κB, AP-1 and SRF/TCF. In: Oxidative Stress, Cell Activation and Viral Infection. Basel: Birkhäuser Basel;1994:217–235. doi:10.1007/978-3-0348-7424-3_20
   Google Scholar
• Buelna-Chontal M, Zazueta C. Redox activation of Nrf2 & NF-κB: a double end sword? Cell Signal. 2013;25(12):2548–2557. doi:10.1016/j.cellsig.2013.08.007
   PubMed Web of Science ®Google Scholar
• Zetterberg H, Schott JM. Biomarkers for Alzheimer’s disease beyond amyloid and tau. Nat Med. 2019;25(2):201–203. doi:10.1038/s41591-019-0348-z
   PubMed Web of Science ®Google Scholar
• Pietronigro E, Zenaro E, Constantin G. Imaging of leukocyte trafficking in Alzheimer’s disease. Front Immunol. 2016;7:33. doi:10.3389/fimmu.2016.00033.
   PubMed Web of Science ®Google Scholar